Jefferies downgraded L&T’s target price due to West Asia exposure, while BoFA Securities maintained a buy on AB Capital, citing strong growth in lending and housing finance. Goldman Sachs issued a sell on Sun Pharmaceuticals, highlighting innovative medicines as a key driver, and Kotak Institutional Equities kept an add rating on Bajaj Finance, emphasizing its structural transformation.
No valid response from Gemini.
